Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020

This article is included in 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
Loading references information
In the context of COVID-19 pandemic, a report on ivermectin suppression of SARS-CoV-2 viral replication in cell cultures has been published, and the use of this medication seems to be potentially useful for the therapy. IVM safety profile and IVM wide spectrum enables to move forward with the investigation in patients infected by SARS-CoV-2 as a proof-of-concept of its possible use in the management of patients with COVID-19, given the current pandemic situation.
Epistemonikos ID: 3d214aaf09432844d8b5eecce7b35a2dda235588
First added on: May 12, 2020